Navigation Links
Ritter Pharmaceuticals Joins NIH Conference Discussions on Lactose Intolerance and Associated Health Risks

LOS ANGELES, Feb. 22 /PRNewswire/ -- Ritter Pharmaceuticals (, a company dedicated to helping individuals live a healthier and happier life style through improved digestion, announced today that it will join the leading lactose intolerance experts around the country at the NIH Consensus Development Conference for Lactose Intolerance and Health in Bethesda, Maryland from February 22-24. The event will discuss topics regarding lactose intolerance and will be focused on answering questions such as the prevalence of lactose intolerance and health outcomes of diets which exclude dairy products.

Today, a significant concern among individuals, including healthcare providers, is that avoidance of dairy products leads to insufficient intake of calcium, vitamin D, and other nutrients. These deficiencies may cause weaker bone health, increased risk of bone fractures, osteoporosis and more serious issues such as hypertension, breast cancer, and colon cancer. Despite the risks associated with a dairy exclusion diet, 70% of the time physicians still recommend dairy avoidance to manage symptoms of lactose intolerance.(1)

"Making sure people eat adequate amounts of dairy is essential, but many lactose intolerant individuals do not choose to do so because of painful or uncomfortable symptoms," said Dennis Savaiano, Ph.D., Dean of the College of Consumer and Family Sciences, Foods and Nutrition at Purdue University and speaker at the upcoming NIH conference.

"Lactagen®, a product unlike any other on the market, is a dietary supplement program taken over 38 days, developed to help reduce symptoms of lactose intolerance," said Andrew Ritter, President and CEO of Ritter Pharmaceuticals, the makers of Lactagen®.  "Clinical data as well as our customers surveyed have shown that Lactagen® is nearly 80% effective at significantly reducing lactose intolerance symptoms."

Lactase supplements often prove to be ineffective or unreliable as reported in a recent study showing that only 26% of lactose intolerant individuals were satisfied with taking lactase supplements.(1)

About Ritter Pharmaceuticals

Ritter Pharmaceuticals is dedicated to helping individuals live a healthier and happier life style through improved digestion.  Ritter Pharmaceuticals focuses on the discovery, development and commercialization of innovative therapeutic treatments for gastrointestinal diseases and conditions.  One of these products is Lactagen®, a dietary supplement developed to help reduce symptoms of lactose intolerance.

(1) "Physicians' and Payors' Perception and Intended Use to Treat Lactose Intolerance." Study performed by Engage Health, June, 2008.

SOURCE Ritter Pharmaceuticals

Back to top



SOURCE Ritter Pharmaceuticals
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Endo Pharmaceuticals Reports Strong Fourth Quarter and Full-Year 2009 Financial Results: Provides 2010 Financial Guidance
2. Alexza Pharmaceuticals Promotes Mark K. Oki to Vice President, Finance and Controller
3. Jazz Pharmaceuticals Announces FDA Acceptance of its New Drug Application for JZP-6 (sodium oxybate) for the Treatment of Fibromyalgia
4. Transdel Pharmaceuticals Announces Management Reorganization
5. Merz Pharmaceuticals Introduces New Mederma(R) Stretch Marks Therapy Now Available in Drugstores Nationwide
6. GlaxoSmithKline President of North America Pharmaceuticals, Deirdre Connelly, Named 2010 Woman of the Year by the Healthcare Businesswomens Association
7. Oramed Pharmaceuticals Expands Scientific Advisory Board With the Appointment of John Amatruda, M.D.
8. Alexza Pharmaceuticals to Host 2010 Investor/Analyst Day on Thursday, February 18, 2010
9. Endo Pharmaceuticals to Announce Fourth Quarter and Full Year 2009 Financial Results on February 22, 2010
10. Amira Pharmaceuticals Announces Efficacy of LPA1 Antagonist in a Preclinical Model of Scleroderma
11. ISTA Pharmaceuticals Announces 2010 Financial Guidance
Post Your Comments:
(Date:12/1/2015)... -- Royal Philips  (NYSE: PHG, AEX: PHIA) ... that produces high-contrast images for all anatomies in situations ... the 2015 Radiological Society of North America Annual ... digital imaging solution providing grid-like contrast improvement and enhanced ... supports "first-time-right imaging" by decreasing the need for retakes ...
(Date:12/1/2015)... 2015 Array BioPharma Inc. (Nasdaq: ... Chief Executive Officer, Ron Squarer , ... Conference in New York.  The public is ... a webcast on the Array BioPharma website. ... --> , --> ...
(Date:12/1/2015)... , Dec. 1, 2015 Pharma Tech Outlook ... Top 10 Clinical Data Management Solution Providers - 2015 ... distinguished panel comprising CEOs, CIOs, VCs, analysts, and the ... illustrious list of top 10 clinical data management solution ... on pages 14 and 36 respectively). ...
Breaking Medicine Technology:
(Date:12/1/2015)... Tampa, FL (PRWEB) , ... December 01, 2015 , ... Florida Hospital Tampa ... the treatment of obesity in the state of Florida. , vBloc® Therapy is a vagal ... age of 18 years with a body mass index (BMI) of at least 40 to ...
(Date:12/1/2015)... ... December 01, 2015 , ... Califia Farms , one of the ... bottle has won top honors in Beverage World Magazine’s Global Packaging Design Awards, taking ... it has been selected as a 2015 U.S.A. Taste Champion in the American Masters ...
(Date:12/1/2015)... ... December 01, 2015 , ... December ... the expansion of the company’s growing product line of food safety and seafood ... and Sockeye (Oncorhynchus nerka) – allow InstantLabs to offer fast, reliable species identification ...
(Date:12/1/2015)... ... December 01, 2015 , ... The workstation boundaries for ... IMAGE Information Systems launches MED-TAB™ -- the world’s first portable DICOM-calibrated medical image ... 29 to December 4, 2015. , MED-TAB is expected to change teleradiology ...
(Date:12/1/2015)... ... December 01, 2015 , ... For ... That is why Hollister Incorporated has launched the VaPro Plus Pocket™ touch free ... in the VaPro touch free catheter portfolio,” said Michael Gresavage, Vice President North ...
Breaking Medicine News(10 mins):